Directorate Change
05 Agosto 2008 - 3:22AM
UK Regulatory
RNS Number : 6407A
Jourdan PLC
05 August 2008
Jourdan plc ("Jourdan" or the "Company")
Paul Hartley appointed Executive Director
Jourdan is pleased to announce that Paul Hartley has today been appointed Executive Director of the Company. The Company also announces
that Bob Morris retired as Group Managing Director on 24 April but remains a Director.
Paul Hartley, age 63, brings a wealth of experience to Jourdan and has been with Westfield Medical for 19 years. Paul has had 15 years
experience as a Local Magistrate and is currently a Director of Sterile Barrier Association, the association of the major companies involved
in the manufacture and distribution of single use sterilisation products. Paul has previously been involved in various manufacturing
companies within the furniture, textile and printing industries in a variety of roles including General Manager, Sales Director and
Manufacturing Director, both in the UK and Europe.
He will retain responsibility for Westfield Medical Limited, Clinipak Limited and assume responsibility for Nelsons Labels (Manchester)
Limited.
AIM Rules Disclosure
Save for the disclosures below, there is no other information that is required to be disclosed under Schedule 2 paragraph (g) of the AIM
Rules.
Current and previous directorships in last 5 years
Clinipak Limited (current)
Nelsons Labels (Manchester) Limited (current)
Sterile Barrier Association (current)
Westfield Medical Limited (current)
The Barrier Test Consortium Limited (company dissolved 4 May 2004)
Contact:
Jourdan plc
David Abell, Chairman Tel: 01476 403456
Charles Stanley Securities Tel: 020 7149 6000
Nominated Adviser & Broker
Russell Cook / Carl Holmes
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAEAPPSEAFPEEE
Jourdan (LSE:JDR)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025
Jourdan (LSE:JDR)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025
Real-Time news about Jourdan (London Stock Exchange): 0 recent articles
Más de Jourdan Plc Artículos de Noticias